Videos

To kick off Hispanic Heritage Month, Katherine Bianco, MD, director of the Maternal Congenital Heart Program, Standford Medicine Children's Health, discusses how a diverse health care population can improve patient outcomes.

Amy Taneja, MD, discusses the results of the RUBY study, which evaluated the efficacy of the JADA device in women with postpartum bleeding and postpartum hemorrhage.

Matthew Zerden, MD, provides various tips and resources for ob-gyn hospitalists wanting to implement postpartum LARCs in their institution, according to his presentation at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois.

John Stanley, MD, details how providers can create an OB hospitalist program , according to his presentation at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois.

Marci Bowers, MD, shares the biggest takeaways from her presentation on transgender reproductive care, presented at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois.

Sean Esplin, MD, maternal-fetal medicine physician, senior medical director for women’s health, professor, Department of OB/GYN, University of Utah, discusses his presentation on advanced fetal heart rate monitoring interpretation at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois.

Jermaine Gray, MD, provides some essential tips for various cases of vulvovaginal conditions that present in the emergency department, which was recently presented at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting.

Angela Dempsey, MD, MPH, gives her insights on how to advocate for your patients in post-Roe America, which was presented during her session at the recent 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois.

Experts outline their clinical approach to identifying treatment failure in patients on initial pharmacologic treatment for OAB and strategies for subsequent treatment selection.

A comprehensive discussion on clinical factors that impact pharmacologic treatment selection in patients with OAB.

Panelists introduce the available treatment modalities for OAB, including behavioral modification, pharmacologic treatment, neuromodulation, and surgical approaches.

Timothy Hand, PhD, associate professor of pediatrics and immunology at the University of Pittsburgh School of Medicine and UPMC Children’s Hospital of Pittsburgh, discusses how antibodies provided from breast milk can improve immunity in infants.

A brief overview of how and when providers incorporate urodynamic testing as part of the diagnostic workup for OAB.

Panelists further expand on the typical clinical characteristics of patients with OAB who they see in their practice, common signs and symptoms, and potential differential diagnoses.

Experts begin their panel discussion on OAB by describing the typical diagnostic process and initial conversations that they have with patients suspected of having the condition.

Urologist Benjamin Brucker, MD, urogynecologist Eman Elkadry, MD, and nurse practitioner Jenna Horton, NP introduce themselves, outline their credentials, and briefly describe the patients with overactive bladder (OAB) who they typically see in their clinical practice.

Hugh Taylor, MD, discusses topic which will be presented at the 4th Annual International Congress on the Future of Women’s Health.

Lori Homa, MD, discusses the opening of a new fertility clinic from Allegheny Health Network.

Monica Christmas, MD, associate professor at the University of Chicago, discusses the findings of a study on how vaginal estrogen may be used to treat urinary symptoms in postmenopausal women, along with how she hopes these findings will impact treatment in women with urinary symptoms.

Emre Seli, MD, chief scientific officer of the March of Dimes, discusses the organization's initiative to research recurrent pregnancy loss.

Sadia Haider, MD, MPH, talks about the latest guidelines from the Society of Family Planning regarding contraception for trans patients, RH testing during pregnancy, and Depo-Provera self-administration at the 2023 ACOG Annual Clinical and Scientific Meeting.

In this video interview, experts provide a synopsis of their presentation about technology and obstetric care at the 2023 ACOG Annual Clinical and Scientific Meeting.

At the 2023 ACOG Annual Clinical and Scientific Meeting, Haywood Brown, MD, discusses the current maternal mortality rate in the United States, as well as disparities affecting different racial and ethnic groups.

At the 2023 ACOG Annual Clinical & Scientific Meeting, Caitlin Martin, MD, discussed the concerning rise in substance use mortalities and maternal mortalities.

Anne Banfield, MD, discusses the highlights from her presentation on primary HPV screening at the 2023 ACOG Annual Clinical and Scientific Meeting in Baltimore, Maryland.

At the 2023 ACOG Annual Clinical & Scientific Meeting, Gloria Richard-Davis MD, MBA, NCMP, FACOG, discussed the importance of using hormone therapies to treat menopause symptoms.

Genevieve Neal-Perry, MD, PhD, talks about the recent approval of fezolinetant (Veozah; Astellas Pharma) and her latest phase 3 research presented at the 2023 ACOG Annual Clinical and Scientific Meeting.

The FDA Advisory Committee recently voted in support of approval for Pfizer's maternal immunization vaccine to help prevent RSV in infants. In this Contemporary Pediatrics® interview, Tina Tan, MD, FAAP, FIDSA, FPIDS, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital, Chicago, explains what this means for this patient population ahead of an expected FDA decision in August, 2023.

Beth Garner, MD, MPH, chief scientific officer, Ferring Pharmaceuticals, talks the current state of fertility in the United States.